however, the evidence supporting this use is limited, and administration should be undertaken with caution [5].The most recent multidisciplinary consensus statement [54] recommends that patients without significant gastrointestinal symptomsdefined as severe nausea, vomiting, or intolerance to oral intakeshould continue GLP-1 RA therapy regardless of the specific agent, with modifications to fasting protocols
2 Association of hypothyroidism and the gut microbiota Recent advances in microbiome research have markedly expanded our understanding of how the gut microbiota critically influences human health, particularly through intricate interactions with endocrine disorders such as hypothyroidism
(Eds.), Endotext [Internet]
It has been studied as a fat burner, to increase performance, speed recovery and to help fight sarcopenia
One of the main reasons is comorbidities like hypertension and diabetes